October 8th 2024
Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a helpful tool.
October 4th 2024
Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.
October 1st 2024
Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic kidney cancer.
September 27th 2024
An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.
The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials
An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.
Kidney Cancer FAQs Answered on Treatments, Care Teams and More
An expert provides answers to pressing questions regarding different aspects of a kidney cancer journey, including stage, grade and treatment options.
Nubeqa Plus ADT Outperformed ADT Alone in Treating Prostate Cancer
Adding Nubeqa to androgen deprivation therapy improved radiographic progression-free survival in patients with metastatic hormone-sensitive prostate cancer.
Keytruda Improves Disease-Free Survival in Some With Urothelial Carcinoma
Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived without signs of cancer.
Swimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More
From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in the oncology space this week.
Survival Rate Increased With Yervoy-Opdivo Combo in Kidney Cancer
The 12-month survival rates in patients with non-clear cell renal cell carcinoma showed improvements after treatment with Yervoy plus Opdivo.
Trodelvy May Improve Responses in Bladder Cancer Subtype
Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed after checkpoint inhibitors.
Presurgical Cetrelimab With TAR-200 Shows Responses in Muscle-Invasive Bladder Cancer
Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of death, research shows.
Welireg Shows Stable Survival Benefits Over Afinitor in Kidney Cancer
Among patients with previously treated advanced clear cell renal cell carcinoma (RCC) Welireg continued to show some benefits, though not to overall survival.
Princess Kate Finishes Chemo, E Street Band Member Announces Diagnosis and More
From Princess Kate entering ‘a new phase of recovery’ to a Rock and Roll Hall of Famer’s blood cancer announcement, here’s what’s happening in the cancer space this week.
Take Life On: My Mantra After Cancer
I stopped pondering why cancer happened to me and instead focused on achieving my goals and taking life on.
Focusing Energy on Cancer-Related Fatigue
Fatigue is a common side effect that may linger for years following cancer treatment. Experts and survivors talk about ways to help find a balance between life and fatigue.
Danielle Fishel of ‘Boy Meets World’ Has Cancer, ‘Emily in Paris’ Star Discusses Her Diagnosis and More
From Danielle Fishel and Rick Steves announcing their diagnosis to the “Emily in Paris” star discussing her cancer experience, here’s what’s happening in the oncology space this week.
What Patients With Kidney Cancer Need to Know About Welireg
One expert explained why ‘it’s very important to know what’s going on’ with regard to new renal cell carcinoma treatments.
ARPIs May Improve Survival in Some With Prostate Cancer
Androgen receptor pathway inhibitors were shown to better treat patients with metastatic castration-resistant prostate cancer and improved survival.
Afinitor May Not Boost Outcomes in Non-Clear Cell Kidney Cancer
Afinitor did not improve relapse-free survival in patients with non-clear cell renal cell carcinoma — a kidney cancer subtype linked to poor prognosis.
Dose-Dense Chemo for Muscle-Invasive Bladder Cancer May Be Feasible
Patients with locally advanced muscle-invasive bladder cancer may benefit from dose-dense gemcitabine and cisplatin.
Feeling Imposter Syndrome in the Cancer Community
Understanding how I fit in matters to me but figuring out my identity in the cancer space is not always easy.
Navigating Nutrition, Frailty During Kidney or Bladder Cancer Is Key
Considering nutrition and frailty earlier on may help patients achieve better health-related quality of life during kidney cancer and bladder cancer.
Genetic Mutations May Predict Chemo Response in Bladder Cancer
Certain genetic mutations were associated with better responses to presurgical chemotherapy in muscle-invasive bladder cancer.
Questions Patients Should Ask After a Cancer Diagnosis
We asked oncology experts what questions patients should ask their doctors soon after receiving a cancer diagnosis. This is their advice.
Pre- and Postsurgical Opdivo Does Not Boost Relapse-Free Survival in Kidney Cancer
Relapse outcomes were similar in patients with high-risk renal cell carcinoma treated with Opdivo and with observation before and after surgery.
Study Analyzes Welireg Side Effects in Kidney Cancer
An analysis of more than 500 patients with advanced kidney cancer treated with Welireg broke down the rates of moderate to severe side effects.
Active Surveillance Viable Option for Some With Prostate Cancer
Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.
FDA Speeds Up Review of Kidney Cancer CAR-T Cell Therapy
The Food and Drug Administration granted a fast track designation to ADI-270, an off-the-shelf CAR-T cell therapy for clear cell renal cell carcinoma.
13 Things I’ve Learned in 2 Years With 2 Cancer Types
I was diagnosed with kidney cancer and pancreatic neuroendocrine tumors two years ago, but I’ve learned a lifetime of lessons since.
Oncology Drug Shortage May Not Lead to Suboptimal Care
Although there are still cancer drugs in short supply, the chief medical officer at the NCCN explained that most patients will not get suboptimal care.
Judge Frank Caprio Talks Pancreatic Cancer Diagnosis, ‘Ink Master’ Star Dies and More
From Judge Frank Caprio opening up about his diagnosis of pancreatic cancer and treatment to an “Ink Master” star dying from testicular cancer, here’s what’s going on in the oncology space this week.
My New Image After Testicular Cancer
After testicular cancer hindered my self-image and identity, I decided to create a five-point system to help me achieve a successful future.
Matters of Faith After a Cancer Diagnosis
Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their grip on faith after a cancer diagnosis.